The rulebook for rare disease therapies will be overhauled to make it quicker and easier to get these therapies tested, manufactured and approved in the UK, the MHRA has announced in a new paper.
Sandwell, West MidlandsBand E, SCP 18-25 (£31,537 – £36,363 per annum)
Skipton, North Yorkshire£31,537 - £34,434 per annum
Sandwell, West MidlandsBand E, SCP 18-25 (£31,537 – £36,363 per annum)
Skipton, North Yorkshire£31,537 - £34,434 per annum